Orcular and ortibal tumors
Conditions
Interventions
Study group:Eye-tracking system
Sponsors
The Clinical Technology Research And Development Center of Shanghai Proton and Heavy Ion Center
Eligibility
Sex/Gender
All
Age
14 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1.Age >= 14 years old and < 80 years old; 2.Diagnosis: Pathologically confirmed orbital tumors; Choroidal melanoma can be diagnosed by imaging; Tumors invasion of orbit; 3.No previous radiotherapy to the orbital area; 4.No distant metastatic lesions; 5.Expected survival of at least 6 months; 6.ECOG score 0-1, without severe pulmonary hypertension, cardiovascular diseases, peripheral vascular diseases, severe chronic heart diseases, etc. which may affect the administration of radiotherapy; 7.Sign the informed consent form before enrollment;
Exclusion criteria
Exclusion criteria: 1.Non-ocular or orbit tumors; 2.Those who have received any radiation therapy or radioactive particle implantation treatment to the eyes or orbit; 3.With poorly controlled distant metastatic lesions; 4.Pregnant women with positive pregnancy test results; 5.With accompanying diseases or conditions that affect the patient's normal enrollment or safety during the study period; 6.Active mental disorders or other psychological disorders that affect the patient's signing of the informed consent form and their understanding ability; 7.Uncontrolled active infections;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Technical requirements for equipment; | — |
Countries
China
Contacts
Public ContactLin Kong
The Clinical Technology Research And Development Center of Shanghai Proton and Heavy Ion Center
Outcome results
None listed